Chief Executive Officer
Chief Financial Officer
Chief Legal Officer & General Counsel – AVICANNA USA INC.
Lucas Nosiglia, MFin
President, Avicanna LATAM
A seasoned entrepreneur and executive with experience across Europe, North America and South America, Lucas has been at the forefront of Avicanna’s Latin America (LATAM) operations since the company’s inception in 2016. His innovative and transformative approach in navigating the cannabis industry and his former involvement in management consulting, finance and health care have been invaluable in establishing and operating the company’s Colombian subsidiaries including two fully operational cultivation projects. Lucas’ experience from working at Deloitte along with his leadership values are at the core of his success in leading Avicanna’s largest teams. Lucas graduated with an Honours degree from Faculty of Economics of University of Buenos Aires and holds a Masters degree in Finance from EADA in Barcelona Spain.
Dr. Frantz Le Devedec
Executive Vice President, Research & Product Development
Executive Vice President, Marketing
Dr. Karolina Urban
Executive Vice President, Scientific and Medical Affairs
Dr. Urban is the Vice President of Scientific and Medical Affairs at Avicanna where she leads the development and execution of Avicanna’s preclinical and clinical research programs including collaborations with leading neurologists, clinicians, and scientists. Dr. Urban also leads the company’s medical affairs and has successfully developed and implemented global training programs for healthcare providers interested in prescribing medical cannabis. Dr. Urban has a MSc in Neurosciences and PhD in Rehabilitation Sciences from the University of Toronto, with expertise in neuroimaging and brain injury. She is a former professional hockey player winning the Clarkson Cup in the C.W.H.L. and an academic all-Canadian. Currently, she is on the board of Scientific Advisors for MYndspan, a brain analytics company, and member of Board of Directors for Kinark Child and Family Services Foundation.
Vice President, Technical Operations
Roland is an experienced pharmacist and regulatory expert with more than 12 years of experience with international pharmaceutical companies. His experience includes his role at the Colombian Regulatory Agency INVIMA, where he was the lead GMP inspector across Latin American and Asian markets. Roland is an expert in GMP and GLP legislation for phyto-therapeutic and allopathic medicines and held membership in the Colombian national committee which developed the country’s GLP and GMP for natural medicines. Roland’s role at Avicanna involves technical leadership in the company’s API manufacturing and quality assurance at a global level. Over the past 5 years, Roland has also led the development and execution of Avicanna’s regulatory and compliance strategies in addition to supporting the company’s pharmaceutical and cosmetic production based in Colombia.
Vice President, Canadian Operations
Vice President, Commercialization
Brennan contributes considerable commercial strategy and management consulting experience that spans across the cannabis, technology, and entertainment industries. Most recently, he championed a top growth platform of international cannabis at Deloitte, where he contributed to establishing the Canadian firm as the cannabis reference amongst Deloitte’s member firms. Brennan’s unique ability to navigate complex international business functions and foster strong relationships has been vital in developing strategic long-term solutions for partners and clients. Brennan leads commercialization efforts at Avicanna across the company’s North American business units while supporting the company’s global commercial strategy. Brennan holds a Bachelor of Commerce (Honours) degree from Queen’s University.
Board of Directors
Dr. Chandra Panchal
Dr. Panchal has been the Chief Executive Officer of Axcelon Biopolymers Corp. since 2008, has authored over seventy scientific papers, holds several patents in oncology, diagnostics, biopolymers and microbiology, and is an Adjunct Professor in Chemical and Biochemical Engineering at the University of Western Ontario. Dr. Panchal currently sits on the board of directors of both an oncology company known as Medicenna Therapeutics Corp. (MDNA), and Canadian Oil Recovery and Remediation Inc. (CVR) as well as Pure Global Cannabis Inc. (PURE). Dr. Panchal holds a Master of Science degree in Molecular Biology and a Ph.D. in Biochemical Engineering from the University of Western Ontario.
Chief Executive Officer
Utilizing his extensive senior management experience in both financial and bio-technology sectors, Aras co-founded Avicanna with the vision of establishing a bio-pharmaceutical company with a strict focus on medical and pharmaceutical applications of cannabinoids. His expertise experience in the biotechnology industry have been integral to Avicanna’s thought leadership pertaining to R&D and clinical development. Since 2016 Aras has successfully led a team of executives, scientists, and medical professionals across several countries with the vision of vertical integration and a strong company focus on quality controls, scientific vigour and competitive advantages. Aras holds a Bachelor of Economics degree from York University and an International master’s in management degree from EADA Business School in Barcelona, Spain.
Dr. Assad J. Kazeminy
Dr. Kazeminy is the founder and former President and CEO of Irvine Pharmaceutical Services Inc. and Avrio Biopharmaceutical LLC. Dr. Kazeminy received his doctorate degree in Pharmaceutical Sciences, graduate studies in Biochemistry and completed his post doctorate at the University of Southern California (USC) Medical School, Department of Pharmacology. Since January 2014, Dr. Kazeminy has been a member of the Chapman University School of Pharmacy (CUSP) Dean’s Professional Advisory Group, has served as a member of the United States Pharmacopeia (USP) Console of Experts 2000-2020 and has been awarded by United States Pharmacopeia a Winner for Innovative Responses to a Public Health Challenge.
Flavio Jose Zaclis
Mr. Zaclis has more than 20 years of experience in private equity, venture capital and entrepreneurial projects. After completing several investment cycles, Mr. Zaclis founded Barn Investimentos in 2012, a venture capital investment boutique, dedicated to early-stage investments in the Brazilian and Latin American markets. Mr. Zaclis is a board member of several companies and has actively participated in initial public offerings, private placements, and merger and acquisition negotiations for portfolio companies. Mr. Zaclis is responsible for fundraising, deal execution, and team leadership at Barn Investimentos.
Business Advisory Board
Dr. Aline Masuda
Dr. Aline D. Masuda is currently an associate professor at EADA Business School in the department of Strategy Leadership and People. She also conducts research in motivation and leadership, employee attitudes, and flexible working arrangements across cultures. She has published in journals such as Journal of Vocational Behavior, Academy of Management Discoveries, Applied Psychology an International Review. She holds Ph.D. and Master’s degrees in Industrial Organizational Psychology from the State University of New York-Albany and Missouri State University respectively. Previously, she was a senior project manager for International Survey Research, currently part of Towers Watson. She also worked at the workforce research and marketing intelligence departments at IBM and was a post-doctoral researcher at IESE Business School.